skip to Main Content

Archive for : Blood Management

Laboratory Test Management Programs

Reducing Blood Transfusions Through an Effective Laboratory Test Management Program It is well known that the longer a patient stays in the hospital, the more likely one is to develop anemia. This could be due to the fact that patients…


The Rational Use of Blood

“Rationalis” – The Rational Use of Blood In the arena of patient blood management, evidence continues to highlight the need for more restrictive transfusion practice over a broad range of clinical subspecialties. As Dr. Chaplin stated so eloquently in the…

Written by: Mediware Consulting and Analytics on Monday, September 28, 2015 Blood Management

Thawed and Liquid Plasma for Massive Transfusion Protocols

Thawed and Liquid Plasma for Massive Transfusion Protocols The most recent National Collection and Blood Utilization Survey, reporting data from 2011, noted US patients received 3.9 million plasma units that year. At 10 hospitals participating in the National Heart, Lung…

Written by: Mediware Consulting and Analytics on Tuesday, September 1, 2015 Blood Management

Plasma Use

Plasma Use in the United States Triulzi D. et al. A multicenter study of plasma use in the United States. Transfusion 2015; 55: 1313-1319 Plasma transfusion, historically, has been steeped in much mystery and myth, with wide variability and inappropriate…

Written by: Mediware Consulting and Analytics on Monday, August 3, 2015 Blood Management

Pathogen Reduction Systems

Pathogen Reduction Systems Attain FDA Approval The US Food and Drug Administration (FDA) deploys a five-layer system to safeguard the volunteer-driven blood system: (1) Donor screening (upfront information about donor eligibility and specific and direct questions), (2) Donor deferral lists…

Written by: Mediware Consulting and Analytics on Tuesday, July 7, 2015 Blood Management

Platelet-Rich Plasma

Platelet-Rich Plasma: My View from the Transfusion Service Platelets play a significant role in primary hemostasis, however they also serve as a reservoir of a number of important growth factors, including but not limited to platelet-derived growth factor (PDGF), vascular…

Written by: Mediware Consulting and Analytics on Tuesday, June 9, 2015 Blood Management

Avoid Sample Rejections

Avoid Sample Rejections Due to Hemolysis Definition: Hemolysis involves breakage of red blood cell (RBC) membrane which causes the release of hemoglobin and other internal components into the surrounding fluid (Plasma). Hemolysis is a widely documented issue for blood samples…

Written by: Mediware Consulting and Analytics on Monday, May 4, 2015 Blood Management

The Transfusion Indication Threshold Study

Commentary: THE TRANSFUSION INDICATION THRESHOLD (TITRe) STUDY Murphy et al. N Engl J Med 2015; 372:997-1008 In the wake of the recently published TITRe study, SHG received numerous queries as to whether this trial casts doubt upon restrictive transfusion practices…

Written by: Mediware Consulting and Analytics on Monday, March 30, 2015 Blood Management

Chronic Kidney Disease

Chronic Kidney Disease: Better Care = Better Outcomes Chronic kidney disease (CKD) is a global health problem.  In the United States, the incidence and prevalence is rising.  CKD results in poor health outcomes, is often associated with and/or caused by…

Written by: Mediware Consulting and Analytics on Monday, March 2, 2015 Blood Management

Hematology and Oncology Blood Management Issues

Issues for Blood Management in Hematology/Oncology Hematology/Oncology patients comprise a unique subpopulation for whom transfusion therapy is often necessary in both the acute care setting as well as for long-term support. Red blood cells (RBCs) and platelets are the most…

Written by: Mediware Consulting and Analytics on Wednesday, January 14, 2015 Blood Management